Rheumatology Journals

Rheumatology

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Radhakrishnan J et al. – The authors found that the response to mycophenolate mofetil (MMF) as induction treatment of patients with class V lupus nephritis (LN) appears to be no different from that to intravenous cyclophosphamide (IVC).

Related Articles

Biomarkers for Lupus Nephritis: The Quest Continues
Clinical Journal of the American Society of Nephrology, 11/13/09    Relevance Score: 68%

Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature
Rheumatology International, 11/13/09    Relevance Score: 67%

Male gender results in more severe lupus nephritis
Rheumatology International, 10/05/09    Relevance Score: 67%

Clinical-Pathological Features and Prognosis of Thrombotic Thrombocytopenic Purpura in Patients With Lupus Nephritis
The American Journal of the Medical Sciences, 11/13/09    Relevance Score: 65%

Diffusion-weighted MR imaging of kidneys in patients with systemic lupus erythematosus: initial experience
Rheumatology International, 10/14/09    Relevance Score: 65%

Today in Clinical Pharmacology...keeping you current

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
Canadian Medical Association Journal, 11/23/09

Effect of Sildenafil on digital ulcers in systemic sclerosis - analysis from a single centre pilot study
Annals of Rheumatic Diseases, 11/23/09

Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address